Our data are consistent with a recent report, in which GPX4 and TXNRD1 were still expressed in diffuse large B-cell lymphoma cell lines apparently deficient in SECISBP2 immunostaining, although it was not further studied what kind of mutations may have caused the lack of SECISBP2 protein [54]. Here, SECISBP2 is linked to diffuse large B-cell lymphoma.